Xuedong Fang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 5
- Molecular Biology top 5%
- RNA modifications and cancer 10
- Biomaterials top 5%
- Oncology top 10%
- Cancer Cells and Metastasis 6
- Colorectal Cancer Surgical Treatments 5
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 6
-
- Immunotherapy and Immune Responses 7
-
- Genetic factors in colorectal cancer 4
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Xuedong Fang
78 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 438
- Molecular Biology 1.3k
- Biomaterials 210
- Oncology 413
- Biomedical Engineering 502
Countries citing papers authored by Xuedong Fang
This map shows the geographic impact of Xuedong Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuedong Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuedong Fang more than expected).
Fields of papers citing papers by Xuedong Fang
This network shows the impact of papers produced by Xuedong Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuedong Fang. The network helps show where Xuedong Fang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuedong Fang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 13 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 43 | |
| 8 | 2022 | 15 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 51 | |
| 11 | 2020 | 40 | |
| 12 | 2019 | 89 | |
| 13 | [Advances in the research of gastric signet ring cell carcinoma]. | 2018 | 3 |
| 14 | 2017 | 29 | |
| 15 | 2017 | 50 | |
| 16 | Expression of eag1 channel associated with the aggressive clinicopathological features and subtype of breast cancer. | 2015 | 4 |
| 17 | 2013 | 30 | |
| 18 | 2013 | 12 | |
| 19 | 2013 | 56 | |
| 20 | 2012 | 19 |
About Xuedong Fang
Xuedong Fang is a scholar working on Oncology, Cancer Research and Immunology, having authored 85 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Immunotherapy and Immune Responses (7 papers), Nanoplatforms for cancer theranostics (6 papers), Cancer Cells and Metastasis (6 papers), Cancer-related molecular mechanisms research (6 papers), Colorectal Cancer Surgical Treatments (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Genetic factors in colorectal cancer (4 papers). The work is most often cited by research in Cancer Research (438 citations), Molecular Biology (1.3k citations) and Biomaterials (210 citations). Xuedong Fang has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Fujian Ji, Fangfang Chen, Qiong Wu, Xiaoqiang Cui, Yanchao Xu, Ying Wang, Guangri Jia, Ningbo Li, Jiandong Wu and Yuanyu Wu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.